Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril

Respirology

Volumn 17, Issue 8, 2012, Pages 1261-1268

  Molthen, Robert C ^a,e,f   Wu, Qingping ^b   Fish, Brian L ^b   Moulder, John E ^b   Jacobs, Elizabeth R ^a,d,f   Medhora, Meetha M ^a,b,c,d,f  

^a Division of Pulmonary and Critical Care   (United States)

^b Departments of Radiation Oncology   (United States)

^c Departments of Physiology   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Medical College of Wisconsin and Marquette University   (United States)

^f Department of Veteran Affairs   (United States)

Author keywords

captopril; injury; lung; pneumonitis; radiation; therapeutics

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY COMPLIANCE; ARTICLE; CONTROLLED STUDY; DENSITY; ENZYME ACTIVITY; FEMALE; IRRADIATION; LUNG HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; PULMONARY VASCULAR DISEASE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED PULMONARY VASCULAR INJURY; RADIATION INJURY; RADIATION PNEUMONIA; RAT; THERAPY DELAY;

ACUTE LUNG INJURY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; FEMALE; LUNG; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PNEUMONITIS; RATS; THORAX; VASCULAR SYSTEM INJURIES;

EID: 84867930386     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02247.x     Document Type: Article

References (48)

1. Augustine AD, Gondre-Lewis T, McBride W, et al,. Animal models for radiation injury, protection and therapy. Radiat. Res. 2005; 164 (1): 100-9.
2. Stone HB, Moulder JE, Coleman CN, et al,. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat. Res. 2004; 162 (6): 711-28.
3. Fleckenstein K, Zgonjanin L, Chen L, et al,. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2007; 68 (1): 196-204.
4. Ghosh SN, Wu Q, Mader M, et al,. Vascular injury after whole thoracic x-ray irradiation in the rat. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74 (1): 192-9.
5. Mehta V,. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63 (1): 5-24.
6. Hill RP,. Radiation effects on the respiratory system. BJR Suppl. 2005; 27: 75-81.
7. Marks LB, Yu X, Vujaskovic Z, et al,. Radiation-induced lung injury. Semin. Radiat. Oncol. 2003; 13 (3): 333-45.
8. Robbins ME, Diz DI,. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64 (1): 6-12.
9. Calveley VL, Khan MA, Yeung IW, et al,. Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. Int. J. Radiat. Biol. 2005; 81 (12): 887-99.
10. Molteni A, Moulder JE, Cohen EF, et al,. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int. J. Radiat. Biol. 2000; 76 (4): 523-32.
11. Ward WF, Molteni A, Kim YT, et al,. Structure-function analysis of angiotensin-converting enzyme inhibitors as modifiers of radiation-induced pulmonary endothelial dysfunction in rats. Br. J. Radiol. 1989; 62 (736): 348-54.
12. Travis EL,. The sequence of histological changes in mouse lungs after single doses of x-rays. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6 (3): 345-7.
13. Ghosh SN, Zhang R, Fish BL, et al,. Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 2009; 75 (5): 1528-36.
14. Ward WF, Lin PJ, Wong PS, et al,. Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography. Radiat. Res. 1993; 135 (1): 81-7.
15. Molteni A, Wolfe LF, Ward WF, et al,. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr. Pharm. Des. 2007; 13 (13): 1307-16.
16. Gross NJ,. The pathogenesis of radiation-induced lung damage. Lung 1981; 159 (3): 115-25.
17. Zhang R, Ghosh SN, Zhu D, et al,. Structural and functional alterations in the rat lung following whole thoracic irradiation with moderate doses: injury and recovery. Int. J. Radiat. Biol. 2008; 84 (6): 487-97.
18. Sealey JE, Laragh JH,. How to do a plasma renin assay. Cardiovasc. Med. 1977; 2: 1079-92.
19. Moulder JE, Cohen EP, Fish BL,. Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat. Res. 2011; 175 (1): 29-36.
20. Molthen R, Wu Q, Krenz G, et al,. Imaging radiation pneumonitis in a rat model of a radiological terrorism incident. In:, Clough AV, Hu XP, (eds) Medical Imaging 2009: Biomedical Application in Molecular, Structural, and Functional Imaging. Proceedings of SPIE. SPIE, Bellingham, WA, 2009.
21. Molthen RC, Karau KL, Dawson CA,. Quantitative models of the rat pulmonary arterial tree morphometry applied to hypoxia-induced arterial remodeling. J. Appl. Physiol. 2004; 97 (6): 2372-84.
22. Linehan JH, Haworth ST, Nelin LD, et al,. A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J. Appl. Physiol. 1992; 73 (3): 987-94.
23. Miska W, Croseck H, Schill WB,. Proteins of the kallikrein-kinin system in human semen. Isolation and properties of kininase II. Andrologia 1990; 22 (Suppl. 1): 178-84.
24. Shingrani R, Krenz G, Molthen R,. Automation process for morphometric analysis of volumetric CT data from pulmonary vasculature in rats. Comput. Methods Programs Biomed. 2010; 97 (1): 62-77.
25. Yesil S, Yesil M, Bayata S, et al,. ACE inhibitors and cough. Angiology 1994; 45 (9): 805-8.
26. Coulter DM, Edwards IR,. Cough and angiotensin converting enzyme inhibitors. Br. Med. J. (Clin. Res. Ed.) 1988; 296 (6625): 863.
27. Ward WF, Solliday NH, Molteni A, et al,. Radiation injury in rat lung. II. Angiotensin-converting enzyme activity. Radiat. Res. 1983; 96 (2): 294-300.
28. Ward WF, Kim YT, Molteni A, et al,. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme. Int. J. Radiat. Oncol. Biol. Phys. 1988; 15 (1): 135-40.
29. Williams JP, Brown SL, Georges GE, et al,. Animal models for medical countermeasures to radiation exposure. Radiat. Res. 2010; 173 (4): 557-78.
30. Iwata M, Cowling RT, Gurantz D, et al,. Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am. J. Physiol. Heart Circ. Physiol. 2005; 289 (6): H2356-63.
31. Liu YH, Yang XP, Sharov VG, et al,. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 1997; 99 (8): 1926-35.
32. Nguyen L, Ward WF, Ts'ao CH, et al,. Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism. Proc. Soc. Exp. Biol. Med. 1994; 205 (1): 80-4.
33. Morrell NW, Morris KG, Stenmark KR,. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am. J. Physiol. 1995; 269 (Heart Circ Physiol 38): H1186-H94.
34. Morrell NW, Atochina EN, Morris KG, et al,. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J. Clin. Invest. 1995; 96: 1823-33.
35. Molthen R, Wu Q, Baumgardt S, et al,. Arterial morphology responds differently to Captopril than N-acetylcysteine in a monocrotaline rat model of pulmonary hypertension. In:, Molthen RC, Weaver JB, (eds) Medical Imaging 2010: Biomedical Application in Molecular, Structural, and Functional Imaging. Proceedings of SPIE. SPIE, Bellingham, WA, 2010.
36. McIff TE, Poisner AM, Herndon B, et al,. Mitigating effects of captopril and losartan on lung histopathology in a rat model of fat embolism. J. Trauma 2011; 70: 1186-91.
37. Wang XM, Zhou TF, Liu B, et al,. [Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions]. Sichuan Da Xue Xue Bao Yi Xue Ban 2009; 40 (2): 255-9.
38. Hislop A, Reid L,. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br. J. Exp. Pathol. 1976; 57 (5): 542-54.
39. van Suylen RJ, Smits JF, Daemen MJ,. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1998; 157 (5 Pt 1): 1423-8.
40. Peterson LM, Evans ML, Graham MM, et al,. Vascular response to radiation injury in the rat lung. Radiat. Res. 1992; 129 (2): 139-48.
41. Vanderpool RR, Kim AR, Molthen R, et al,. Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function. J. Appl. Physiol. 2011; 110 (1): 188-98.
42. Champion HC, Michelakis ED, Hassoun PM,. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009; 120 (11): 992-1007.
43. Sniderman AD, Fitchett DH,. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure. Int. J. Cardiol. 1988; 20 (2): 173-81.
44. Arkles JS, Opotowsky AR, Ojeda J, et al,. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2011; 183 (2): 268-76.
45. Okada K, Bernstein ML, Zhang W, et al,. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am. J. Respir. Crit. Care Med. 1998; 158 (3): 939-50.
46. Molteni A, Ward WF, Ts'ao C, et al,. Monocrotaline-induced cardiopulmonary injury in rats: modification by the nonthiol ACE inhibitors CGS13945 and CGS16617. Arch. Int. Pharmacodyn. Ther. 1988; 291: 21-40.
47. Jeffery TK, Wanstall JC,. Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function. Br. J. Pharmacol. 1999; 128 (7): 1407-18.
48. Herget J, Pelouch V, Kolar F, et al,. The inhibition of angiotensin converting enzyme attenuates the effects of chronic hypoxia on pulmonary blood vessels in the rat. Physiol. Res. 1996; 45 (3): 221-6.